期刊文献+

联合检测心肌肌钙蛋白Ⅰ和超敏C-反应蛋白在急性心肌梗死诊断中的意义 被引量:10

Diagnostic value of combined detection of cTnI and hs-CRP in patients with acute myocardial infarction
下载PDF
导出
摘要 目的探讨心肌肌钙蛋白I(cTnI)和超敏C-反应蛋白(hs-CRP)联合检测对急性心肌梗死(AMI)的诊断价值。方法检测192例AMI患者不同时段血清cTnI和hs-CRP水平,同时检测200例健康体检者血清cTnI和hs-CRP作对照,并对结果进行统计学分析。结果 AMI组与对照组cTnI和hs-CRP浓度比较有差异有统计学意义(P〈0.01),cTnI在AMI胸痛发作12~24 h达到峰值,峰值为(9.68±2.64)μg/L;hs-CRP在AMI胸痛发作8~12 h达到峰值,峰值为(14.5±5.9)mg/L。cTnI和hs-CRP对AMI诊断灵敏度在AMI发作0~8 h和3~7 d差异均有统计学意义,8 h至3 d诊断灵敏度差异无统计学意义,cTnI和hs-CRP对AMI诊断特异度分别为98.5%和84.0%。结论 cTnI诊断AMI具有很高的特异性和较宽的诊断时间,hs-CRP对AMI的早期诊断具有很高的敏感性,二者联合检测可以更好的发挥cTnI和hs-CRP诊断AMI的优点,争取AMI早诊断、早治疗和减少对AMI漏诊、误诊,为AMI诊断提供必要的信息。 Objective To explore the clinical significance of combined detection of cardiac troponin I(cTnI) and high sensitivity C-reactive protein(hs-CRP) in diagnosis of acute myocardial infarction(AMI).Methods The serum concentration of cTnI and hs-CRP were detected in 192 patients with AMI and 200 normal people.Results The serum concentration of cTnI and hs-CRP in AMI group were significantly higher than that in the control group(P0.01).cTnI reached the peak[(9.68 ±2.64)μg/L] at 12~24 h and hs-CRP reached the peak [(14.5±5.90)mg/L] at 8~12 h after chest pain in AMI.The sensitivity of cTnI and hs-CRP in diagnosis of AMI had significant difference in 0~8 h and 3~7 d after chest pain while no significant difference in 8 h~3 d.The specificity of cTnI and hs-CRP was 98.5% and 84.0%respectively.Conclusion cTnI has high specificity in diagnosis of AMI and wide diagnosis time while hs-CRP has high sensitivity.The early diagnosis and treatment may be improved and some information of the infarction moment may be provided if they are measured together.
出处 《检验医学与临床》 CAS 2011年第3期260-261,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献5

二级参考文献27

  • 1曲红,张荣玲,张立英.心肌酶CK-MB和肌钙蛋白I检测的临床意义[J].现代医药卫生,2005,21(6):717-717. 被引量:3
  • 2罗军,刘云兵.心肌肌钙蛋白在心血管病诊治中的应用[J].国外医学(临床生物化学与检验学分册),2005,26(1):38-39. 被引量:37
  • 3郭占军,赵华,郭爱芹,杨焕云.心肌肌钙蛋白I测定及其在急性冠状动脉综合征中的应用[J].国外医学(临床生物化学与检验学分册),2005,26(6):364-366. 被引量:30
  • 4Se-Kyung OH,Kimberly F,Pradip D,et al.Altered regulatory properties of human cardiac troponin I mutants that cause hypertrophic cardiomyopathy[J] Clin Biochem 2000,33(4)255-262.
  • 5Shi QW,Ling MF,Zheng X C,et al.Degradation of cardiac troponin I in serum complicates comparisons of cardiac troponin I assays[J].Clinical Chemistry,1999,451018-1025.
  • 6Katrukha A G, Bereznikova A V,Filatov V L,et al.Degradation of cardiac troponin I:implication for reliable immunodetection[J].Clin Chem,1998,44(12)2433-2440.
  • 7Giuliani I,Berinchant J P,Granier C,et al.Determination of cardiac troponin I forms in the blood of patients with acute myocardial infarction and patients receiving crystalloid or cold blood cardioplegia[J].Clin Chem,1999,45213-222.
  • 8Liu S,Zhang MY,Song Q,et al.Recombinant single chain cardiac troponin I-C polypeptides:superior calibration and control materials for cardiac troponin I immunoassays[J].Clin Lab,2001,47(1-2)19-27.
  • 9Larue C,Calzolari C,Bertinchant J,et al.Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction[J].Clin Chem,1993,39972-979.
  • 10Apple F S,Henry T D,Berger C R,et al.Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolitic therapy[J].Am J Clin Pathol,1996,105(1)6-10.

共引文献605

同被引文献70

引证文献10

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部